After two patients died and serveral more were sickened by drug-resistant bacteria traced to endoscopes, many want to know who dropped the ball, the manufacturer or regulators.
FDA publishes its final guidance on reprocessing medical devices in healthcare settings as news of contaminated duodenoscopes fill headlines.
EndoGastric Solutions has slowly been building clinical evidence to back up claims about its device to treat gastroesophageal reflux disease, and its efforts are finally paying off.
The UCLA cases are not the first outbreak linked to hard-to-clean duodenoscopes, but stricter sterilization steps beyond FDA recommendations may help hospitals avoid more infections.
Minimally invasive surgery has been facilitated by the development of microcameras that can peer into tiny body cavities. The development of microcameras , in turn, has been facilitated by advancements in the area of integrated circuits. A case in point is the micro ScoutCam line of cameras. ...
After coming under fire from shareholders for stagnating growth, intravascular imaging firm Volcano Corp. hopes to right the ship by selling out to Philips.
Royal Philips is buying diagnostic imaging firm Volcano boosting the latter's prospects, but the news for the overall U.S. diagnostics imaging market is less than rosy.
Anders Wold, president and CEO of GE Healthcare Ultrasound, explained how the company is using a decentralized organization, miniaturization, and smartphones to tap into opportunities around the world.
A neurosurgeon, Neal Kassell, writes about the potential of a new technology called focused ultrasound that reduces risk, improves outcomes and lowers cost that should be attractive to hospitals in the future.
6. Agfa-Gevaert The Belgian company makes analog and digital imaging for the healthcare and printing industries mainly.
Covidien has been one of the more active acquiring medtech companies in recent years. CEO Jos é Almeida offers some insight into the company's acquistion strategy.
Avelas Biosciences wants to use this money to conduct first-in-man studies to test its cancer visualization technology.
Covidien is acquiring Given Imaging firm for $860 in a bid to expand business in gastrointestinal diseases.
Gene sequencing and diagnostic imaging can work together to help patients with colon cancer.